Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients
- Status
- UNKNOWN
- Phase
- N/A
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
- Status
- RECRUITING
- Phase
- PHASE2
First in Human, Dose Escalation, Dose Expansion Study of AUR105
- Status
- TERMINATED
- Phase
- PHASE1
Improving Exercise Capacity With a Tailored Physical Activity Intervention
- Status
- RECRUITING
- Phase
- NA
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
- Status
- COMPLETED
- Phase
- PHASE2
Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs
- Status
- UNKNOWN
- Phase
- N/A
MargheRITA (Remote Intelligence for Therapeutic Adherence)
- Status
- COMPLETED
- Phase
- NA
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
- Status
- RECRUITING
- Phase
- N/A